Capital Point Ltd. sold 0.72% stake in NeuroDerm Ltd. (NasdaqGM:NDRM) for $3 million on December 16, 2015. Capital Point sold approximately 0.15 million shares of NeuroDerm at a price of approximately $19.7 per share.

Capital Point Ltd. completed the sale of 0.72% stake in NeuroDerm Ltd. (NasdaqGM:NDRM) on December 16, 2015.